What is the upside for OPKO Health's stock?
Their forecasts range from $5.00 to $7.00. On average, they expect OPKO Health's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 24.0% from the stock's current price. View analysts' price targets for OPKO Health or view top-rated stocks among Wall Street analysts.
What kind of company is OPKO Health?
Quote :: OPKO Health, Inc. (OPK) OPKO Health, Inc. is a diversified healthcare company that seeks to serve unmet patient needs and establish industry-leading positions in large, rapidly growing markets. Our diagnostics business includes BioReference Laboratories, one of the…
What are the earnings earnings for OPKO Health (OPK)?
OPKO Health, Inc. (NASDAQ:OPK) released its earnings results on Thursday, October, 28th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.05.
Where can I buy shares of OPK?
Shares of OPK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is opko stock a good buy?
Is Opko Health Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPK) stock is to Buy OPK stock.
Who owns OPKO Health company?
Dr. Phillip FrostAt OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs.
Does OPKO Health pay dividends?
OPKO Health, Inc. has not declared or paid cash dividends. The company has retained earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
Will OPK stock go up?
The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 6.25, with a high estimate of 8.50 and a low estimate of 5.00. The median estimate represents a +137.64% increase from the last price of 2.63.
Is opko shorted?
OPKO Health (OPK -7.54%) is a highly shorted stock -- 24% of its float is sold short.
What does OPKO Health make?
OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Should I keep my OPK stock?
There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OPKO Health stock. View analyst ratings for OPKO Health or view top-rated stocks.
What is Opk new price target?
Stock Price Target OPKHigh$8.50Median$6.25Low$5.00Average$6.50Current Price$2.81
Is Xela Stock good?
The financial health and growth prospects of XELA, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
When will OPKO Health release its earnings?
How much does Opko Health make?
OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021. View our earnings forecast for OPKO Health.
Stock Price Forecast
OPKO Health has a market capitalization of $2.36 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.05 on an earnings per share basis.
Analyst Recommendations
The 4 analysts offering 12-month price forecasts for OPKO Health Inc have a median target of 7.00, with a high estimate of 8.50 and a low estimate of 6.00. The median estimate represents a +118.75% increase from the last price of 3.20.
Business
Risks
- 2 equities research analysts have issued 1-year target prices for Opko Health's stock. Their predictions range from $5.00 to $20.00. On average, they anticipate Opko Health's share price to reach $12.50 in the next year. This suggests a possible upside of 489.6% from the stock's current price. View Analyst Price Targets for Opko Health.
Ratings
- 2 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Opko Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Opko Health.
Reception
- Headlines about OPK stock have trended neutral this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Opko Health e…
Ownership
- Opko Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.90%), Dimensional Fund Advisors LP (0.70%), Wells Fargo & Company MN (0.24%), RK Asset Management LLC (0.19%), Fosun International Ltd (0.14%) and Pictet Asset Management Ltd. (0.11%). Company insiders that own Opko Health stock include A…
Operations
- Opko Health has a market capitalization of $1.31 billion and generates $990.30 million in revenue each year. The biotechnology company earns $-153,040,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Opko Health employs 5,690 workers across the globe.
Access
- Opko Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at 305-575-4100 or via email at [email protected].